Key result
Amiodarone use was associated with marked QTc prolongation and syncope due to torsades de pointes or ventricular fibrillation in five patients.
Why the study?
Does amiodarone cause torsades de pointes or ventricular fibrillation in patients treated for arrhythmias?
Case Report (n=5)
Does amiodarone cause torsades de pointes or ventricular fibrillation in patients treated for arrhythmias?
Answers are grounded in this paper and cite their sources.
Amiodarone can induce marked QTc prolongation leading to life-threatening torsades de pointes or ventricular fibrillation, particularly in patients with predisposing factors like hypokalemia or prior drug-induced arrhythmias.
Five cases of amiodarone-induced syncope due to torsades de pointes or ventricular fibrillation are described. Amiodarone was used for recurrent supraventricular tachycardia in four cases and frequent ventricular extra systoles complicating congenital QT prolongation in the remaining case. Each was associated with a marked prolongation in the QTc interval following amiodarone. Three cases had had a previous history of life-threatening ventricular arrhythmias secondary to anti-arrhythmic drugs. Hypokalemia may have been a contributory factor in two. The clinical features, predisposing factors, and treatment are discussed.
No takes yet. Share an insight, caveat, or question.
Brown et al. (1986) conducted a case report in Amiodarone-induced syncope due to torsades de pointes or ventricular fibrillation (n=5). Amiodarone was evaluated on Syncope due to torsades de pointes or ventricular fibrillation. Amiodarone use was associated with marked QTc prolongation and syncope due to torsades de pointes or ventricular fibrillation in five patients.
Synapse has enriched 10 related papers. Consider them for comparative context: